Authors: GROSSMAN R KUHN MJ MARAVILLA K LEE D SCHILD H ETHIER R REISER M YUH WTC OLUKOTUN AY

Citation: R. Grossman et al., MULTICENTER EVALUATION OF THE SAFETY, TOLERANCE, AND EFFICACY OF OPTIMARK IN MAGNETIC-RESONANCE-IMAGING OF THE BRAIN AND SPINE, Academic radiology, 5, 1998, pp. 154-155

Authors: OLUKOTUN AY PARKER JR MEEKS MJ LUCAS MA FOWLER DR LUCAS TR

Citation: Ay. Olukotun et al., SAFETY OF GADOTERIDOL INJECTION - US CLINICAL-TRIAL EXPERIENCE, Journal of magnetic resonance imaging, 5(1), 1995, pp. 17-25

Authors: MCLACHLAN SJ MORRIS MR LUCAS MA FISCO RA EAKINS MN FOWLER DR SCHEETZ RB OLUKOTUN AY

Citation: Sj. Mclachlan et al., PHASE-I CLINICAL-EVALUATION OF A NEW IRON-OXIDE MR CONTRAST AGENT, Journal of magnetic resonance imaging, 4(3), 1994, pp. 301-307

Authors: OLUKOTUN AY

Citation: Ay. Olukotun, CONTRAST-MEDIA COST-ANALYSIS .2., Journal of the American College of Cardiology, 23(3), 1994, pp. 826-827

Authors: OLUKOTUN AY

Citation: Ay. Olukotun, SAFETY OF MR CONTRAST-MEDIA, Radiology, 191(2), 1994, pp. 584-585

Authors: ASHLEY RA CARVLIN MJ LUCAS TP OLUKOTUN AY

Citation: Ra. Ashley et al., ADDRESSING COST-CONTAINMENT AND COST-EFFECTIVENESS IN MAGNETIC-RESONANCE CONTRAST AGENT DEVELOPMENT, Investigative radiology, 29, 1994, pp. 190000257-190000259